Utilization Management & Prior Authorization

Synthesis:

In the last 24 hours, national attention has sharpened around CMS’s use of prior authorization as a lever for both cost containment and care quality in Medicare—an issue now described by stakeholders as a “dirty word” but positioned as potentially the most effective tool for reform under value-based models. Tensions continue to mount as MA plans, ACOs, and provider groups navigate evolving CMS policy signals under the Trump administration, with renewed policy debate on whether prior authorization aligns with broader VBC objectives or creates administrative barriers stifling care innovation and population health management. For health system and payer strategists, the discussion directly impacts the structure and scalability of risk-based contracts and the operational burden of care transformation initiatives (‘Prior Authorization’ Has Become a Dirty Word in Healthcare, But it Might Be Medicare’s Smartest Path Forward.